Atria Wealth Solutions Inc. Takes Position in Gevo, Inc. $GEVO

Atria Wealth Solutions Inc. acquired a new position in shares of Gevo, Inc. (NASDAQ:GEVO) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 150,000 shares of the energy company’s stock, valued at approximately $174,000. Atria Wealth Solutions Inc. owned approximately 0.06% of Gevo at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. Y Intercept Hong Kong Ltd bought a new position in Gevo during the first quarter valued at approximately $36,000. WNY Asset Management LLC purchased a new stake in shares of Gevo in the first quarter worth $58,000. Cannon Global Investment Management LLC purchased a new stake in shares of Gevo in the first quarter worth $58,000. Centerpoint Advisory Group boosted its position in shares of Gevo by 55.6% during the first quarter. Centerpoint Advisory Group now owns 56,000 shares of the energy company’s stock worth $65,000 after acquiring an additional 20,000 shares during the last quarter. Finally, Jefferies Financial Group Inc. bought a new position in shares of Gevo during the fourth quarter worth $189,000. Institutional investors own 35.17% of the company’s stock.

Analysts Set New Price Targets

GEVO has been the subject of several research reports. HC Wainwright reiterated a “buy” rating and set a $14.00 price objective on shares of Gevo in a research report on Friday, May 30th. Wall Street Zen raised shares of Gevo from a “sell” rating to a “hold” rating in a research note on Saturday.

Insider Activity at Gevo

In other Gevo news, COO Christopher Michael Ryan sold 73,934 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $1.28, for a total value of $94,635.52. Following the transaction, the chief operating officer directly owned 1,510,000 shares in the company, valued at $1,932,800. This represents a 4.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP L Lynn Smull sold 60,331 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $1.28, for a total transaction of $77,223.68. Following the completion of the transaction, the executive vice president owned 1,109,271 shares in the company, valued at $1,419,866.88. This represents a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 974,354 shares of company stock worth $1,225,620. 4.00% of the stock is owned by corporate insiders.

Gevo Stock Down 2.2%

NASDAQ:GEVO opened at $1.80 on Monday. The company has a current ratio of 2.33, a quick ratio of 2.10 and a debt-to-equity ratio of 0.29. The company’s 50 day moving average is $1.41 and its two-hundred day moving average is $1.33. Gevo, Inc. has a twelve month low of $0.66 and a twelve month high of $3.39. The company has a market cap of $435.31 million, a PE ratio of -6.92 and a beta of 2.67.

Gevo (NASDAQ:GEVO) last issued its quarterly earnings results on Monday, August 11th. The energy company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.07. Gevo had a negative net margin of 72.76% and a negative return on equity of 12.04%. The company had revenue of $43.41 million during the quarter, compared to analyst estimates of $43.69 million. Analysts anticipate that Gevo, Inc. will post -0.42 EPS for the current year.

Gevo Profile

Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.